Episodes
-
Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
April 23rd, 2024 | Season 1 | 1 hr 4 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring presentations from the 2023 ASH annual meeting on the management of myelofibrosis and other myeloproliferative neoplasms moderated by Dr Neil Love. Produced by Research To Practice.
-
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
April 15th, 2024 | Season 1 | 37 mins 19 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the role of HER2-directed therapy in the treatment of gastrointestinal tumors, moderated by Dr Neil Love. Produced by Research To Practice.
-
Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
April 12th, 2024 | Season 1 | 1 hr 35 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring updates for the management of CLL and Richter’s transformation from ASH 2023 with Dr Bita Fakhri, moderated by Dr Neil Love. Produced by Research To Practice
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
April 5th, 2024 | Season 1 | 58 mins 42 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of colorectal cancer with Professor Thierry André and Dr Arvind Dasari, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
April 5th, 2024 | Season 1 | 1 hr 56 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of urothelial bladder cancer with Dr Shilpa Gupta and Prof Thomas Powles, moderated by Dr Neil Love. Produced by Research To Practice.
-
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
April 3rd, 2024 | Season 1 | 1 hr 14 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on early research and available data with B7-H3-targeted antibody-drug conjugates with Dr Manish Patel, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
March 27th, 2024 | Season 1 | 1 hr 1 min
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on clinical data from the past year on the management of prostate cancer with Drs Andrew Armstrong and Maha Hussain, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
March 26th, 2024 | Season 1 | 1 hr 13 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of lymphoma with Dr Andrew M Evens and Dr Sonali M Smith, moderated by Dr Neil Love. Produced by Research To Practice.
-
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
March 25th, 2024 | Season 1 | 1 hr 19 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy.
-
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
March 21st, 2024 | Season 1 | 1 hr 1 min
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of hepatobiliary cancers with Dr Robin K (Katie) Kelley and Dr Mark Yarchoan, moderated by Dr Neil Love. Produced by Research To Practice.
-
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
March 19th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the role of approved and investigational antibody drug conjugates for non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
March 15th, 2024 | Season 1 | 1 hr 5 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of HER2-positive and triple-negative breast cancer with Dr Ian E Krop and Dr Priyanka Sharma, moderated by Dr Neil Love. Produced by Research To Practice.
-
Virtual Case Library: Metastatic Urothelial Bladder Cancer
March 13th, 2024 | Season 1 | 2 hrs 8 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a roundtable discussion of patient cases and relevant recent research on metastatic urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
March 11th, 2024 | Season 1 | 37 mins 32 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on available and investigational oral SERDs in the management of ER-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
March 8th, 2024 | Season 1 | 1 hr 4 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on optimal management approaches for myelofibrosis with Dr Stephen T Oh, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
March 6th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on gastroesophageal cancers with Dr Yelena Y Janjigian and Dr Zev Wainberg, moderated by Dr Neil Love. Produced by Research To Practice.